These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36212476)

  • 41. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
    Huang J; Song J; Li X; Liu S; Huang W; Shen Z; Cheng Y; Kou S; Gao Z; Tian Y; Hu J
    BMC Med Genomics; 2022 Jul; 15(1):164. PubMed ID: 35879790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis.
    Zhang J; Zhang B; Wang T; Wang H
    Int J Clin Exp Med; 2015; 8(4):5499-505. PubMed ID: 26131129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PD-1/PD-L1 expression in pancreatic cancer and its implication in novel therapies.
    Mucileanu A; Chira R; Mircea PA
    Med Pharm Rep; 2021 Oct; 94(4):402-410. PubMed ID: 36105495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Far upstream element-binding protein 1 is up-regulated in pancreatic cancer and modulates immune response by increasing programmed death ligand 1.
    Fan P; Ma J; Jin X
    Biochem Biophys Res Commun; 2018 Nov; 505(3):830-836. PubMed ID: 30301530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression.
    Zheng NN; Zhou M; Sun F; Huai MX; Zhang Y; Qu CY; Shen F; Xu LM
    World J Gastroenterol; 2020 Jul; 26(26):3737-3749. PubMed ID: 32774054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer.
    Zhang H; Zhao L; Li S; Wang J; Feng C; Li T; Du X
    Front Oncol; 2021; 11():697949. PubMed ID: 34178697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The METTL3/MALAT1/PTBP1/USP8/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis.
    Shu B; Zhou YX; Li H; Zhang RZ; He C; Yang X
    Cell Death Discov; 2021 Nov; 7(1):368. PubMed ID: 34839365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer.
    Xue MQ; Wang YL; Wang JC; Wang XD; Wang XJ; Zhang YQ
    Sci Rep; 2022 Jun; 12(1):10082. PubMed ID: 35710698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.
    Sun Z; Liu J; Liu J
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):72-78. PubMed ID: 32538750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. m
    Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
    EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model.
    Jung JY; Ryu HJ; Lee SH; Kim DY; Kim MJ; Lee EJ; Ryu YM; Kim SY; Kim KP; Choi EY; Ahn HJ; Chang S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment.
    Cao PW; Liu L; Li ZH; Cao F; Liu FB
    Front Genet; 2022; 13():853471. PubMed ID: 35547245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer.
    Yu X; Dong P; Yan Y; Liu F; Wang H; Lv Y; Song M; Yao Q; Hu S
    Front Cell Dev Biol; 2021; 9():748442. PubMed ID: 34621754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.
    Imai D; Yoshizumi T; Okano S; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Soejima Y; Aishima S; Oda Y; Maehara Y
    Cancer Med; 2017 Jul; 6(7):1614-1626. PubMed ID: 28602029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer.
    Yan R; Li J; Zhou Y; Yao L; Sun R; Xu Y; Ge Y; An G
    Life Sci; 2020 Jan; 241():117150. PubMed ID: 31837335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues.
    Liu JH; Chen G; Dang YW; Li CJ; Luo DZ
    Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer.
    Li Z; Li Y; Zhong W; Huang P
    J Oncol; 2021; 2021():7488188. PubMed ID: 34349798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.